Pediatric Pulmonary Vascular Disease or Adult Pulmonary Vascular Disease

The Challenge in Burden of Pulmonary Arterial Hypertension: A Perspective From the Global Burden of Disease Study

Yicheng Yang, Zhiwei Zeng, Qiaoxi Yang, Huan Wang, Hanwen Zhang, Wenjie Yan, Peizhi Wang, Chuangshi Wang, Zhanhao Su, Pugazhenthan Thangaraju, Sher Zaman Safi, Beilan Yang, Yaoyao Wang, Jingjing Zhou, Zhiyong Zou, Yuan Huang, Songren Shu, Changming XiongFuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College. Anzhen Hospital […]

The Challenge in Burden of Pulmonary Arterial Hypertension: A Perspective From the Global Burden of Disease Study Read More »

GATA2 Deficiency With Early-Onset and Progressive Interstitial Lung Disease

Yuriko Sugiura, Takahiro Ando, Hirokazu Urushiyama, Akihisa Mitani, Goh Tanaka, Kenichi Kashimada, Tomohiro Morio, Hidenori KageUniversity of Tokyo. Institute of Science Tokyo.Japan Respirology Case ReportsRespirol Case Rep 2025; 13: DOI: 10.1002/rcr2.70165 AbstractGATA2 deficiency is a rare disease caused by germline heterozygous variants. This mutation is known to cause a decrease in haematopoietic stem cells and a

GATA2 Deficiency With Early-Onset and Progressive Interstitial Lung Disease Read More »

Reduced Right Ventricular Size and Function in Adolescents and Adults Born Preterm

Zachary W. Blair, Alvin Chandra, Gregory P. Barton, Nataly Sanchez Solano, Jarett D. Berry, Kara N. GossUniversity of Texas Southwestern Medical Center. Parkland Health. University of Texas Health Tyler. United States Journal of the American Society of EchocardiographyJ Am Soc Echocardiogr 2025; DOI: 10.1016/j.echo.2025.04.007 AbstractBackground: Adults born premature have smaller cardiac chamber sizes, and some develop right

Reduced Right Ventricular Size and Function in Adolescents and Adults Born Preterm Read More »

Localization, Proteolytic Processing, and Binding Partners of Versican Isoforms in Vascular Lesions of Pulmonary Arterial Hypertension

Christian Westöö, Ayse Ceren Mutgan, Oscar van der Have, Timothy J. Mead, Salaheldin Ahmed, Elna Lampei, Christopher D. Koch, Christian Norvik, Anders Aspberg, Martin Bech, Niccolò Peruzzi, Hans Brunnström, Grazyna Kwapiszewska, Göran Rådegran, Suneel S. Apte, Karin Tran-LundmarkLund University. Medical University of Graz. Skåne University Hospital. Cleveland Clinic Lerner Research Institute. Case Western Reserve University. University Hospitals Rainbow Babies & Children’s Hospital. Helsingborg Hospital. Sanford School of Medicine and University of South Dakota. German Center for Lung Research Sweden, Austria, United States

Localization, Proteolytic Processing, and Binding Partners of Versican Isoforms in Vascular Lesions of Pulmonary Arterial Hypertension Read More »

Risk stratification in Eisenmenger syndrome

Estibaliz Valdeolmillos, Athenaïs Boucly, Marc Humbert, Olivier Sitbon, Laurent Savale, David Montani, Jérôme Le Pavec, Elie Fadel, Magalie Ladouceur, Emmanuelle Fournier, Gregoire Albenque, Bastien Provost, Clément Batteux, Alain Fraisse, Michael A. Gatzoulis, Aleksander Kempny, Sebastien HascoëtHôpital Marie Lannelongue, les hôpitaux Paris Saint-Joseph et Marie Lannelongue and Université Paris-Saclay. Hôpitaux Universitaires de Genève. Royal Brompton Hospital.

Risk stratification in Eisenmenger syndrome Read More »

Konar-MF™: Versatile Utility Suggests Potential to Simplify Congenital Catheterization Laboratory Inventory

Navaneetha Sasikumar, Pranoti Toshniwal. Usha Mandikal Kondakarna Sastry, Shweta Bakhru, Jayaranganath Mahimarangaiah, Nageshwara Rao Koneti, Raman Krishna KumarAmrita Institute of Medical Sciences. Sri Jayadeva Institute of Cardiovascular Sciences and Research. Rainbow Children’s Hospital.India Pediatric CardiologyPediatr Cardiol 2025; DOI: 10.1007/s00246-025-03849-x AbstractKONAR-MF™ device is a novel, cone-shaped, medium profile, self-expanding, double-disk, nitinol occlusive device designed for the ventricular

Konar-MF™: Versatile Utility Suggests Potential to Simplify Congenital Catheterization Laboratory Inventory Read More »

Novel Use of Drug-Coated Balloon Angioplasty to Treat Pulmonary Vein Stenosis

Saloni Agrawal, Kali A. Hopkins, Ali N. Zaidi, Barry LoveMount Sinai Hospital. Mount Sinai Fuster Heart Hospital.United States Journal of the American College of Cardiology Case ReportsJACC Case Rep 2024; 29: DOI: 10.1016/j.jaccas.2024.102613 AbstractPulmonary vein stenosis is challenging to treat due to high rate of recurrence. Multiple interventions exist but are limited by high rates of

Novel Use of Drug-Coated Balloon Angioplasty to Treat Pulmonary Vein Stenosis Read More »

The Role of Genetics in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension

Fatma Hayvaci Canbeyli, Kazim Secgen, Faith Suheyl Ezgu, Gulten Tacoy, Serkan Unlu, Hidayet Ozan Arabaci, Ayhan Pektas, Asli Inci, Ergun Baris Kaya, Umit Yasar Sinan, Mehmet Serdar Kucukoglu, Serdar KulaGazi University Faculty of Medicine. Istanbul University Faculty of Medicine. Afyonkarahisar University of Health Sciences. Hacettepe University Faculty of Medicine. Turkey Pediatric CardiologyPediatr Cardiol 2025; DOI: 10.1007/s00246-025-03847-z

The Role of Genetics in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension Read More »

Cellular Communication Network Protein 2 in the Right Ventricle of Pulmonary Arterial Hypertension

Carly E. Byrd, Jennifer E. Schramm, Jun Yang, Allan E. Barnes, Megan Griffiths, Anjira S. Ambade, Darin T. Rosen, Ilton M. Cubero Salazar, Catherine E. Simpson, Ryan J. Tedford, Steven Hsu, Dhananjay Vaidya, Todd M. Kolb, Michael W. Pauciulo, William C. Nichols, David D. Ivy, Eric D. Austin, Paul M. Hassoun, Rachel L. Damico, Allen

Cellular Communication Network Protein 2 in the Right Ventricle of Pulmonary Arterial Hypertension Read More »

Eliglustat and cardiac comorbidities in Gaucher disease: a pharmacogenomic approach to safety and efficacy

Noor Ul Ain, Armaan Saith, Audrey Ruan, Ruhua Yang, Aaron Burton, Pramod K. MistryYale School of Medicine and Yale New Haven Hospital.United States Frontiers in MedicineFront Med 2025; 12: DOI: 10.3389/fmed.2025.1535099 AbstractIntroduction: Gaucher disease (GD), a lysosomal storage disorder, results from the accumulation of glycosphingolipids due to deficient lysosomal glucocerebrosidase activity. This pathological accumulation triggers immune activation,

Eliglustat and cardiac comorbidities in Gaucher disease: a pharmacogenomic approach to safety and efficacy Read More »

Scroll to Top